Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31falseActivities of other holding companietrue12024-01-01false1 12782096 2024-01-01 2024-12-31 12782096 2023-01-01 2023-12-31 12782096 2024-12-31 12782096 2023-12-31 12782096 c:Director1 2024-01-01 2024-12-31 12782096 d:CurrentFinancialInstruments 2024-12-31 12782096 d:CurrentFinancialInstruments 2023-12-31 12782096 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 12782096 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 12782096 d:ShareCapital 2024-12-31 12782096 d:ShareCapital 2023-12-31 12782096 d:RetainedEarningsAccumulatedLosses 2024-12-31 12782096 d:RetainedEarningsAccumulatedLosses 2023-12-31 12782096 c:FRS102 2024-01-01 2024-12-31 12782096 c:Audited 2024-01-01 2024-12-31 12782096 c:FullAccounts 2024-01-01 2024-12-31 12782096 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12782096 c:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 12782096










PSLAB - RE LIMITED










FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
PSLAB - RE LIMITED
REGISTERED NUMBER: 12782096

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note

Fixed assets
  

Investments
 4 
1,998
1,998

  
1,998
1,998

Current assets
  

Debtors: amounts falling due within one year
 5 
7,827
7,827

  
7,827
7,827

Creditors: amounts falling due within one year
 6 
(999)
(999)

Net current assets
  
 
 
6,828
 
 
6,828

Total assets less current liabilities
  
8,826
8,826

  

Net assets
  
8,826
8,826


Capital and reserves
  

Called up share capital 
  
23,826
23,826

Profit and loss account
  
(15,000)
(15,000)

  
8,826
8,826


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




J El Saddi Chaya
Director

Date: 23 December 2025

The notes on pages 2 to 5 form part of these financial statements.

Page 1

 
PSLAB - RE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

The company is a private company limited by shares, and is incorporated in England and Wales. The
address of its registered office is 14th Floor, 33 Cavendish Square, London, United Kingdom, W1G 0PW.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Exemption from preparing consolidated financial statements

The Company is a parent company that is also a subsidiary included in the consolidated financial statements of a larger group by a parent undertaking established under the law of any part of the United Kingdom and is therefore exempt from the requirement to prepare consolidated financial statements under section 400 of the Companies Act 2006.

 
2.3

Going concern

The financial statements have been prepared on a going concern basis as the Company's parent undertaking has confirmed they will not seek repayment of amounts due until such time the Company has sufficient net assets.

 
2.4

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is .

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Profit and loss account within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 2

 
PSLAB - RE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.7

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are
Page 3

 
PSLAB - RE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.7
Financial instruments (continued)

initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.
 

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 1).

Page 4

 
PSLAB - RE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

4.


Fixed asset investments





Investments in subsidiary companies




Cost


At 1 January 2024
1,998



At 31 December 2024
1,998





5.


Debtors

2024
2023


Amounts owed by group undertakings
7,827
7,827



6.


Creditors: Amounts falling due within one year

2024
2023

Amounts owed to group undertakings
999
999

999
999



7.


Controlling party

The smallest group for which consolidated financial statements are prepared which include the results of this company is that headed by PSLab Holding Limited, whose registered office is 14th Floor 33 Cavendish Square, London, W1G 0PW.


8.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 23 December 2025 by James Hallett ACA (Senior statutory auditor) on behalf of Sumer Auditco Limited.

Page 5